Matthew D Stevenson (Matt Stevenson)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Topics

Systematic Review

Chronic Myeloid Leukemia

Cross Sectional

Top Venues

Health technology assessment (Winchester, England)

PharmacoEconomics

Journal of medical economics

Addiction (Abingdon, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Steve Goodacre, Laura Sutton, Kate Ennis, Benjamin David Thomas, Olivia Hawksworth, Khurram Iftikhar, Susan Jane Croft, Gordon Ward Fuller, Simon Waterhouse, Prof Daniel Hind, Matthew D Stevenson, Michael Bradburn, Michael Anthony Smyth, Gavin D Perkins, Mark Millins, Andy Rosser, Jon Mark Dickson, Matthew Wilson
Prehospital early warning scores for adults with suspected sepsis: the PHEWS observational cohort and decision-analytic modelling study. Health technology assessment (Winchester, England) 28 (16) (2024)
Steve Goodacre, Laura Sutton, Kate Ennis, Benjamin David Thomas, Olivia Hawksworth, Khurram Iftikhar, Susan Jane Croft, Gordon Ward Fuller, Simon Waterhouse, Prof Daniel Hind, Matthew D Stevenson, Michael Bradburn, Michael Anthony Smyth, Gavin D Perkins, Mark Millins, Andy Rosser, Jon Mark Dickson, Matthew Wilson
Prehospital early warning scores for adults with suspected sepsis: the PHEWS observational cohort and decision-analytic modelling study. Health technology assessment (Winchester, England) 28 (16) (2024)
Steve Goodacre, Laura Sutton, Kate Ennis, Benjamin David Thomas, Olivia Hawksworth, Khurram Iftikhar, Susan Jane Croft, Gordon Ward Fuller, Simon Waterhouse, Prof Daniel Hind, Matthew D Stevenson, Michael Bradburn, Michael Anthony Smyth, Gavin D Perkins, Mark Millins, Andy Rosser, Jon Mark Dickson, Matthew Wilson
Prehospital early warning scores for adults with suspected sepsis: the PHEWS observational cohort and decision-analytic modelling study. Health technology assessment (Winchester, England) 28 (16) (2024)
Steve Goodacre, Laura Sutton, Kate Ennis, Benjamin David Thomas, Olivia Hawksworth, Khurram Iftikhar, Susan Jane Croft, Gordon Ward Fuller, Simon Waterhouse, Prof Daniel Hind, Matthew D Stevenson, Michael Bradburn, Michael Anthony Smyth, Gavin D Perkins, Mark Millins, Andy Rosser, Jon Mark Dickson, Matthew Wilson
Prehospital early warning scores for adults with suspected sepsis: the PHEWS observational cohort and decision-analytic modelling study. Health technology assessment (Winchester, England) 28 (16) (2024)
Georgina Nakafero, Matthew J Grainge, Hywel C Williams, Tim Card, Maarten W Taal, Guruprasad Padur Aithal, Christopher P Fox, Christian D Mallen, Danielle A van der Windt, Matthew D Stevenson, Richard D Riley, Abhishek Abhishek
Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK. BMJ (Clinical research ed.) 381 (2023)
Andrew Metry, Abdullah Pandor, Shijie Ren, Andrea Shippam, Mark Clowes, Paul Dark, Ronan McMullan, Matthew D Stevenson
Cost-effectiveness of therapeutics for COVID-19 patients: a rapid review and economic analysis. Health technology assessment (Winchester, England) 27 (14) (2023)
Peter Murphy, David Glynn, Sofia Dias, Robert Hodgson, Lindsay Claxton, Lucy Beresford, Katy Cooper, Paul Tappenden, Kate Ennis, Alessandro Grosso, Kath Wright, Anna Cantrell, Matthew D Stevenson, Stephen Palmer
Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework. Health technology assessment (Winchester, England) 25 (76) (2022)
Christopher N Graham, Crystal Watson, Arie Barlev, Matthew D Stevenson, Vikas R Dharnidharka
Mean lifetime survival estimates following solid organ transplantation in the US and UK. Journal of medical economics 25 (1) (2022)
Matthew D Stevenson, Andrew Metry, Michael Messenger
Modelling of hypothetical SARS-CoV-2 point of care tests for routine testing in residential care homes: rapid cost-effectiveness analysis. Health technology assessment (Winchester, England) 25 (39) (2021)
Nanxin Li, Eileen K Sawyer, Konrad Maruszczyk, Gregory F Guzauskas, Marta T Slomka, Tom Burke, Antony Paul Martin, Jamie O'Hara, Matthew D Stevenson, Michael Recht
Adult lifetime cost of hemophilia B management in the US: payer and societal perspectives from a decision analytic model. Journal of medical economics 24 (1) (2021)
Matthew D Stevenson, Andrew Metry, Michael Messenger
Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis. Health technology assessment (Winchester, England) 25 (21) (2021)
Kyla H Thomas, Michael N Dalili, José Antonio López-López, Edna Keeney, David M Phillippo, Marcus R Munafo, Matthew D Stevenson, Deborah M Caldwell, Nicky J Welton
Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta-analysis of randomized controlled trials. Addiction (Abingdon, England) (2021)
Kyla H Thomas, Michael N Dalili, José Antonio López-López, Edna Keeney, David M Phillippo, Marcus R Munafo, Matthew D Stevenson, Deborah M Caldwell, Nicky J Welton
Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis. Health technology assessment (Winchester, England) 25 (59) (2021)
Matthew D Stevenson, Abdullah Pandor, Jean Hamilton, John Stevens, Clare Rowntree, Marrissa Martyn-St James, Andrew Rawdin, Ruth Wong
Ponatinib for Treating Acute Lymphoblastic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics 36 (7) (2019)
Abdullah Pandor, Matthew D Stevenson, John Stevens, Marrissa Martyn-St James, Jean Hamilton, Jenny Byrne, Claudius Rudin, Andrew Rawdin, Ruth Wong
Ponatinib for Treating Chronic Myeloid Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics 36 (8) (2019)